Drug profile · INN
ziprasidone mesylate
ZIPRASIDONE MESYLATE
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
ziprasidone mesylate (ZIPRASIDONE MESYLATE) is an FDA-listed pharmaceutical active ingredient. Route of administration: intramuscular. Current US regulatory status: approved.
Key facts
INN ziprasidone mesylate
Brand ZIPRASIDONE MESYLATE
Route INTRAMUSCULAR
Formulation POWDER
Frequently asked questions
What is ziprasidone mesylate?
ziprasidone mesylate (ZIPRASIDONE MESYLATE) is an FDA-listed pharmaceutical active ingredient. Route of administration: intramuscular. Current US regulatory status: approved.
What is the brand name for ziprasidone mesylate?
ZIPRASIDONE MESYLATE is a marketed brand name for ziprasidone mesylate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of ziprasidone mesylate?
ziprasidone mesylate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.